Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Darutab vs Prezista (darunavir 600 mg) co-administered with Norvir (ritonavir 100 mg) under fed conditions
TCTR20170503002Completed
- Sponsor
- Government Pharmaceutical Organization
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of darunavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Government Pharmaceutical Organization. Started Jul 2017; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on TCTR20170503002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170503002.